Genentech Bets $418M-Plus on AC Immune's ALZ Drug - June 18, 2012

Having trouble viewing this email? View in Browser.

Monday, June 18, 2012  |   |   |   |  Scottish Development International: Home of Breakthrough Science and Future Innovation Scotland is the ideal location for your business. Independent analysis shows that Scotland is a high quality, cost effective location to establish your business project. Enter your details to access our FREE Financial Times benchmarking reports on a range of industries that demonstrate Scotland's competitiveness.   •  Genentech (RHHBY) Bets $418 Million-Plus on AC Immune SA's ALZ Drug More... •  Merck & Co., Inc. (MRK) Bets Up to $303 Million on Ambrx, Inc.'s "Smart Bomb" Antibodies More... •  Infinity Pharmaceuticals Inc. (INFI) Pulls Plug On Cancer Drug Saridegib Trials, Shares Plunge -2.22(15.99%) @ 10:07AM EDT More... •  FDA Focuses on Toxic Side Effects With Onyx Pharmaceuticals, Inc. (ONXX) Drug More... •  Sanofi Pasteur (SASY.PA) Recalls Tuberculosis Vaccine Over Contamination Concerns More... •  FDA Staff Question Value of Sanofi (France) (SAN.PA) Blood Clot Drug More... •  Quintiles, Inc. (QTRN) Deepens Investment in China; to Open Bio-medicine Lab in Shanghai More... •  Takeda Pharmaceutical Co. Ltd. (TKDG.DE) to Stop Selling 13 Pfizer Inc. (PFE) Drugs in Japan More... More Top News Fast and simple RNA sequencing by Invitrogen: The Ion PGM™ Sequencer puts RNA-Seq within reach of any lab, providing a fast, affordable, easy-to-use system for expression analysis of miRNA and mRNA. Offering better sensitivity, the Ion PGM™ Sequencer generates data superior to that obtained using microarrays-for a comparable price. Please click here for more information. •  Vitamin D Plus Calcium Tied to Longer Life, Aarhus University Study More... •  Alcohol Dependence "May Be Influenced By Genes, Washington University Reveals More... •  Cancer's Next Magic Bullet May Be Magic Shotgun, University of California, San Francisco (UCSF) Study More... •  10,000 Microbe Species Live on Your Body, Washington University in St. Louis Study More... •  High Cholesterol Diet Helps Mice With Fatal Genetic Disease, Max Planck Institute of Experimental Medicine Study More... •  Antioxidant Shown to Reduce Blindness Risk in Extremely Premature Babies, Brigham and Women's Hospital Study More... •  Control Gene For "Conveyor Belt" Cells Could Help Improve Oral Vaccines, Treat Intestinal Disease, Emory University School of Medicine Study More... •  Internet Usage Patterns Could Signal Depression, Missouri University of Science and Technology Study More...   More Featured News Laboratory & Pharmaceutical Equipment: Surplus to Ongoing Operations of Sanofi-Aventis! Please click here for more information. • Biotech Bay (San Francisco, California) Catalyst Biosciences, Inc. Scientist, Molecular Biology Responsible for all aspects of Catalyst's phage display platform for identifying therapeutically relevant leads. S/he will generate large libraries of proteases, utilize Catalyst's proprietary selection technology, as well as work with the automation team to develop and utilize screens for characterizing phage hits. • Biotech Beach (San Diego, California) Genomics Institute of the Novartis Research Foundation Scientific Associate, Malaria Drug Discovery Will integrate with a multi-disciplinary team focused on discovery and development of small molecule inhibitors for the treatment of malaria. Primary responsibilities will include investigations into the mechanism of action for novel antimalarials, routinely test efficacy of lead compounds in an in vivo mouse malaria model, and assist in the characterization of compounds in an established high-content screen. • Genetown (Cambridge, Massachusetts) Millennium: The Takeda Oncology Company Senior Product Manager - Hematologic Malignancies Will report to the Global Marketing Director and will assume responsibility for supporting short- and long-term global marketing strategies, programs and tactics to optimize commercial potential for an oncology product in hematologic malignancies. • Pharm Country (Parsippany, New Jersey) Watson Pharmaceuticals, Inc. Project Coordinator Supports and contributes to establishment and documentation of appropriate strategies, deliverables and comprehensive cross-functional project plans for new product development projects (e.g. task analysis, work breakdown structures, time and event schedules, cost projections, resource requirements and risk/contingency plans). • BioCapital (Gaithersburg, Maryland) MedImmune, LLC QA Specialist III - ATS Responsible for assuring the quality of licensed products manufactured at MedImmune and contractors. The Specialist supports a number of functional areas including manufacturing, facilities and other Quality departments. Implements quality policies, manages quality systems and assists in facilitating regulatory compliance inspections. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 BIO Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Massachusetts region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • 2012 BIO Career Fair, Boston, MA June 18, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Product Profiles: Non-Small Cell Lung Cancer • Analysis of marketed NSCLC drugs - development history, key clinical trial data, and assessment of clinical and commercial attractiveness. • Analysis of marketed drugs in comparison to current standard of care. • In-depth analysis of late-stage pipeline drugs - development overview, SWOT analysis, and assessment of clinical and commercial attractiveness. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404 U.S.A. Phone: 650-574-3000 Fax: 650-522-5800 Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. More Company Profiles FREE Subscription to Contract Pharma Devoted to pharmaceutical and biopharmaceutical contract services outsourcing, Contract Pharma is a must read for the pharmaceutical/biopharmaceutical industry professional. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.